Nuveen Multi-Strategy Income And Growth Fund Announces Shareholder Approvals Regarding Portfolio Repositioning
Nuveen Investments, a leading global provider of investment services to
institutions as well as individual investors, today announced that
shareholders of the Nuveen Multi-Strategy Income and Growth Fund (NYSE:
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that shareholders of the Nuveen Multi-Strategy Income and Growth Fund (NYSE: JPC) approved changes necessary to implement the repositioning of the fund’s portfolio at a special shareholder meeting held November 18, 2011. The repositioning of the fund’s portfolio is expected to commence in early 2012, and is intended to increase the attractiveness of the fund’s common shares and narrow the fund’s trading discount by simplifying its investment mandate to a preferred-focused strategy. More details on the repositioning can be found in the JPC Portfolio Repositioning Overview by clicking here: http://www.nuveen.com/Home/Documents/Default.aspx?fileId=53908. Shareholders will be notified once the portfolio repositioning has been completed. Nuveen Investments provides high quality investment services designed to help secure the long-term goals of institutions and individual investors as well as the consultants and financial advisors who serve them. Nuveen Investments markets a wide range of specialized investment solutions which provide investors access to capabilities of its high-quality boutique investment affiliates - Nuveen Asset Management, NWQ, Santa Barbara, Symphony, Tradewinds and Winslow Capital. In total, Nuveen Investments had more than $207 billion of assets under management as of October 31, 2011. For more information, please visit the Nuveen Investments website at www.nuveen.com.
For the week of November 9, TheStreet awaits quarterly results from WhiteWave Foods (WWAV), Dish Network (DISH), Priceline (PCLN), Cisco Systems (CSCO), Macy's (M), Kohl's (KSS), Viacom (VIAB) and more.